Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > 03681 SINOMAB BIO-B > Detailed Quotes

03681 SINOMAB BIO-B

1.8000.0000.00%
Closed 09/30 16:08 CCT
High
1.830
Open
1.830
Turnover
153.67K
Low
1.630
Pre Close
1.800
Volume
84.90K
Market Cap
1.81B
P/E(TTM)
Loss
52wk High
3.250
Shares
1.01B
P/E(Static)
Loss
52wk Low
0.830
Float Cap
1.81B
Bid/Ask %
76.97%
Historical High
7.300
Shs Float
1.01B
Volume Ratio
0.52
Historical Low
0.830
Dividend TTM
--
Div Yield TTM
--
P/B
2.72
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.01%
Amplitude
11.11%
Avg Price
1.810
Lot Size
300
Float Cap
1.81B
Bid/Ask %
76.97%
Historical High
7.300
Shs Float
1.01B
Volume Ratio
0.52
Historical Low
0.830
Dividend TTM
--
P/B
2.72
Dividend LFY
--
Turnover Ratio
0.01%
Amplitude
11.11%
Avg Price
1.810
Lot Size
300
Price Forecast

No Data

News

Comment

Company Overview More
China Antibody Pharmaceutical Co., Ltd. is a Hong Kong biopharmaceutical company specializing in the research, development, manufacture and commercialization of immune disease therapy. The company mainly develops biological agents and new chemical entities based on monoclonal antibodies. The company's main product, SM03, is a potential monoclonal antibody for the treatment of rheumatoid arthritis. The company develops drugs to treat rheumatoid arthritis, systemic lupus erythematosus, asthma, smallpox, dryness syndrome and other immune diseases.
CEO: Ruian Liang
Market: Hong Kong motherboard
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...